Literature DB >> 32977345

[WHO Guidelines on Tuberculosis Infection Prevention and Control].

Claudia Christof1, Barbara Nußbaumer-Streit1, Gerald Gartlehner1,2.   

Abstract

BACKGROUND: Despite considerable progress in the fight against tuberculosis, it is still the most deadly bacterial infectious disease worldwide. Every year, up to 10 million people worldwide still die of tuberculosis. The World Health Assembly has set itself the goal of reducing the number of tuberculosis deaths by 90% and the number of new infections by 80% by 2030. Prevention and infection control measures in public health facilities and wherever the risk of transmission of the tuberculosis bacterium "Mycobacterium tuberculosis" is high are especially important.
OBJECTIVE: The aim of the guideline is to provide updated and evidence-based recommendations for public health measures to prevent the spread of the tuberculosis bacterium in clinical settings and in tuberculosis management.
METHODOLOGY: The World Health Organization (WHO) developed these recommendations according to the methods outlined in the WHO handbook for guideline development. This publication is a summary of the most important aspects of this guideline translated into German by members of the WHO Collaborating Centre at the Danube University Krems (Austria).
RESULTS: This guideline takes into account the current evidence base and provides recommendations and comments on the implementation of tuberculosis prevention and control measures at the level of health care institutions and at the national level. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32977345     DOI: 10.1055/a-1241-4321

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  4 in total

1.  Determinants of Multidrug-Resistant Mycobacterium tuberculosis Infection: A Multicenter Study from Southern Ethiopia.

Authors:  Abdulkerim Badgeba; Mulugeta Shegaze Shimbre; Mathewos Alemu Gebremichael; Biruk Bogale; Menur Berhanu; Hanan Abdulkadir
Journal:  Infect Drug Resist       Date:  2022-07-05       Impact factor: 4.177

2.  Levofloxacin Use in Patients with Suspected Tuberculosis in a Community Hospital, Thailand: A Pilot Study.

Authors:  Thanawat Khongyot; Sawitree Laopaiboonkun; Throngpon Kawpradid; Kannuwat Jitkamrop; Tawee Chanphakphoom; Suriyon Uitrakul
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-06-03

3.  Acceptance of an Informational Antituberculosis Chatbot Among Korean Adults: Mixed Methods Research.

Authors:  Agnes Jihae Kim; Jisun Yang; Yihyun Jang; Joon Sang Baek
Journal:  JMIR Mhealth Uhealth       Date:  2021-11-09       Impact factor: 4.773

4.  Magnitude of tuberculosis and its associated factors among under-five children admitted with severe acute malnutrition to public hospitals in the city of Dire Dawa, Eastern Ethiopia, 2021: multi-center cross-sectional study.

Authors:  Kendalem Asmare Atalell; Ribka Nigatu Haile; Masresha Asmare Techane
Journal:  IJID Reg       Date:  2022-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.